| ¿µ¹® | neurotransmitter | ÇÑ±Û | ½Å°æÀü´Þ¹°Áú |
|---|---|---|---|
| ¼³¸í | ü³»ÀÇ ½Å°æ ¼¼Æ÷¿¡¼ ¹æÃâµÇ¸ç ÀÎÁ¢ÇÏ´Â ½Å°æ¼¼Æ÷³ª ±ÙÀ°¿¡ Á¤º¸¸¦ Àü´ÞÇÏ´Â ¹°Áú. ½Å°æ¼¼Æ÷³»¿¡¼ ÇÕ¼ºµÇ¾î¼ ½Å°æÁ¾¸»ÀÇ ¿¬Á¢¼ÒÆ÷¿¡ ÀúÀåµÈ´Ù. Àڱؿ¡ ÀÇÇØ¼ ¿¬Á¢°£±Ø¿¡ À¯¸®µÇ¾î¼ ¼ö¿ëü¿Í °áÇÕÇÏ¿© Á¤º¸¸¦ ´ÙÀ½ ¼¼Æ÷·Î ÀüÇÑ´Ù. Àü±âÀûÀ¸·Î°¡ ¾Æ´Ï¶ó ÈÇй°Áú¿¡ ÀÇÇØ¼ ¿¬Á¢°£±ØÀ» °ÅÃÄ Á¤º¸¸¦ ÀüÇϱ⠶§¹®¿¡ ÈÇÐÀü´Þ¹°ÁúÀ̶ó°íµµ ÇÑ´Ù. ¿¬Á¢Èĸ·(°æ¿ì¿¡ µû¶ó¼ ¿¬Á¢Àü¸·)À» ÈïºÐ(Å»ºÐ±Ø)½ÃŰ´Â ÈïºÐ¼ºÀü´Þ¹°Áú°ú ¾ïÁ¦(°úºÐ±Ø)ÇÏ´Â ¾ïÁ¦¼º Àü´Þ¹°ÁúÀÌ ÀÖ´Ù. ¾Æ¼¼Æ¿Äݸ°, ³ë¸£¿¡Çdz×ÇÁ, µµÆÄ¹Î, ±Û¸®½Å, ¥ã-¾Æ¹Ì³ëºäÄ¥»ê(GABA)µî °°Àº ½Å°æÀü´Þ¹°ÁúÀÌ¶óµµ ¼ö¿ëü¿¡ µû¶ó¼ ÈïºÐ¼º°ú ¾ïÁ¦¼ºÀ¸·Îµµ ÀÛ¿ëÇÏ´Â °Íµµ ÀÖ´Ù. |
||
| ¿µ¹® | iodine uptake | ÇÑ±Û | ¿ä¿Àµå ¼·Ãë |
|---|---|---|---|
| ¼³¸í | ¼Ò·®ÀÇ 131I¸¦ °æ±¸ Åõ¿© ÈÄ 2, 6, 12, 24½Ã°£ µî ÀÏÁ¤ÇÑ ½Ã°£ °æ°ú ÈÄ °©»ó»ù¿¡¼ÀÇ ¼·ÃëÀ²À» ÃøÁ¤ÇÏ´Â °ÍÀ¸·Î Àü¹ÝÀû °©»ó»ù ±â´É »óŸ¦ ÃøÁ¤ÇÏ´Â °Ë»ç¹ýÀÌ´Ù. |
||
| MAOI | MonoAmine Oxidase Inhibitors |
|---|---|
| NT, Nt | NeuroTransmitter |
| BNT | Boston Naming Test; brain neurotransmitter |
| APUD | Amine Precursor Uptake & Decarboxylation |
| 131I | radioactive Iodine(used in Thyroid uptake, Liver & Kidney Scans & Treatment of malignant & nonmalig... |
| SSRI | Specific serotonin re-uptake inhibitors |
|---|---|
| Uptake-1 | uptake |
| AChE-I | acetylcholine esterase inhibitors |
| ChEI | Cholinesterase inhibitors |
| IAPs | Inhibitors of apoptosis |
| neurotransmitter uptake inhibitors | Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects. (12 Dec 1998) |
|---|
| adrenergic uptake inhibitors | Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (antidepressive agents, tricyclic) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (12 Dec 1998) |
|---|---|
| serotonin uptake inhibitors | Compounds that specifically inhibit the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent. These agents have been used in treatment of depression, panic disorder, obsessive-compulsive behaviour, and alcoholism, as analgesics, and to treat obesity and bulimia. Many of the adrenergic uptake inhibitors also inhibit serotonin uptake; they are not included here. (12 Dec 1998) |
| dopamine uptake inhibitors | Drugs that block the transport of dopamine into axon terminals or into storage vesicles within terminals. most of the adrenergic uptake inhibitors also inhibit dopamine uptake. (12 Dec 1998) |
| receptors, neurotransmitter | Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behaviour of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses. (12 Dec 1998) |
| peptide neurotransmitter | Small peptides used as primary or co transmitters in nerve cells for example FMRF amide, FLRFamide. (18 Nov 1997) |
| neurotransmitter | Any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell. Among the many substances that have the properties of a neurotransmitter are acetylcholine, noradrenaline, adrenaline, dopamine, glycine, y aminobutyrate, glutamic acid, substance P, enkephalins, endorphins and serotonin. (18 Nov 1997) |
| neurotransmitter agents | Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (12 Dec 1998) |
| neurotransmitters and neurotransmitter agents | A collective grouping for neurotransmitters and substances that act on the neurotransmitter system. (12 Dec 1998) |
| neurotransmitter system | A group of nerve cells that use the sameneurotransmitter to communicate. (22 May 1997) |
| Amine Precursor Uptake and Decarboxylation | <pharmacology, physiology> Paracrine cells of which argentaffin cells are an example. Usage of the term APUD is neither helpful nor memorable. Acronym: APUD (11 Nov 1997) |
| gallium uptake with normal chest film | <radiology> Pulmonary drug toxicity, tumour infiltration, sarcoidosis, pneumocystis carinii see: lung: gallium imaging (12 Dec 1998) |
| radioactive iodide uptake test | A test of thyroid function in which 131I-iodide is given orally; after 24 hours, the amount present in the thyroid gland is measured and compared with normal values. Synonym: radioactive iodide uptake test, RAI test. (05 Mar 2000) |
| iodine uptake test | A test of thyroid function in which 131I-iodide is given orally; after 24 hours, the amount present in the thyroid gland is measured and compared with normal values. Synonym: radioactive iodide uptake test, RAI test. (05 Mar 2000) |
| T3 uptake test | A test of thyroid function in which triiodothyronine (T3) is added to a patient's serum in vitro to measure the relative affinities of serum proteins and of an added competitive substance for T3; higher T3 uptakes are associated with hyperthyroidism. Synonym: T3 uptake test. (05 Mar 2000) |
| triiodothyronine uptake test | A test of thyroid function in which triiodothyronine (T3) is added to a patient's serum in vitro to measure the relative affinities of serum proteins and of an added competitive substance for T3; higher T3 uptakes are associated with hyperthyroidism. Synonym: T3 uptake test. (05 Mar 2000) |
Synonyms : Inhibitors, Neurotransmitter Uptake, Uptake Inhibitors, Neurotransmitter, Inhibitors, Neurotransmitter Reuptake, Neurotransmitter Reuptake Inhibitors
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|